Reclaim Your Voice With Micaela Erlanger, Prominent Celebrity Stylist And Author Of “How To Accessorize: A Perfect Finish To Every Outfit”In the dynamic field of women's health, the quest for effective treatments for chronic conditions is ceaseless. Among these conditions, abnormal uterine bleeding , also known as heavy menstrual bleeding, poses a significant yet often under-discussed challenge for millions of women worldwide.
Currently, there is no FDA-approved treatment specifically for acute AUB. This leaves healthcare providers to rely on off-label solutions that fail to address the immediate need to stop bleeding. Theoffers clinical guidance based on studies of off-label use of existing treatments, but innovation in this space has been stagnant for nearly two decades. This lack of advancement underscores a dire need for novel solutions that can provide immediate relief and address the root causes of AUB.
Avana Health's solution is a groundbreaking drug-plus-device approach. It uses an existing off-patent drug previously FDA-approved for other vascular indications and delivered through a proprietary device. The combination of which is intended to stop uterine bleeding. The drug acts on locally disrupted blood vessels to stop the bleeding in minutes regardless of the underlying AUB cause. The device is uniquely designed for intrauterine delivery of the drug and for administration only.
The importance of Avana Health's work extends beyond the realm of healthcare; it is a step towards increasing access to care for women that live in low and high resource settings. In a society where women's health issues are often marginalized, Avana Health's commitment to addressing AUB is a beacon of progress.Abnormal uterine bleeding is a pervasive issue with profound implications for women's health and the economy.